You have 9 free searches left this month | for more free features.

nerve growth factor (NGF)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nerve Growth Factor Expression in Pediatric Severe Burns:Pilot

Completed
  • Burns
  • pediatric patients affected by severe burns
  • Rome, Italy
    Giorgio Conti
Mar 1, 2023

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Ischemic Stroke Trial in Hangzhou (nerve growth factor, physiological saline, EA)

Recruiting
  • Ischemic Stroke
  • nerve growth factor
  • +3 more
  • Hangzhou, Zhejiang, China
    The Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Dec 14, 2022

Corneal Disease, Neuropathy Trial in Boston (Cenegermin-Bkbj)

Withdrawn
  • Corneal Disease
  • Neuropathy
  • Boston, Massachusetts
    Tufts Medical Center
Jan 18, 2023

Ischemic Stroke Trial in Hangzhou (Nerver growth factor (NGF) injection, Placebo injection, EA intervention)

Recruiting
  • Ischemic Stroke
  • Nerver growth factor (NGF) injection
  • +3 more
  • Hangzhou, Zhejiang, China
    The Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Jul 26, 2022

Brain-derived Neurotrophic Factor Single Nucleotide Gene

Recruiting
  • Allergic Rhinitis
  • Genotyping.
  • Sohag, Egypt
    Sohag university Hospital
Jun 15, 2023

New Daily Persistent Headache Biomarkers Study

Terminated
  • New Daily Persistent Headache
  • New Daily Persistent Headache (NDPH)
    • Bronx, New York
      Montefiore Headache Center
    Feb 15, 2022

    Mixed Urinary Incontinence Trial in Bucheon, Seoul (Midurethral slings (MUS))

    Completed
    • Mixed Urinary Incontinence
    • Midurethral slings (MUS)
    • Bucheon, Korea, Republic of
    • +1 more
    Nov 28, 2019

    Acute Ischemic Stroke Trial in Nanjing (Nerve Growth Factors, normal saline)

    Completed
    • Acute Ischemic Stroke
    • Nerve Growth Factors
    • normal saline
    • Nanjing, Jiangsu, China
      Department of Neurology, Jinling Hospital
    Aug 29, 2021

    Breast Cancer Trial in Damanhur (Placebo, Fenofibrate 160mg)

    Recruiting
    • Breast Cancer
    • Placebo
    • Fenofibrate 160mg
    • Damanhūr, Elbehairah, Egypt
      Damanhour Oncology Center
    Apr 1, 2023

    Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)

    Completed
    • Dry Eye Syndrome
    • rhNGF 20 µg/mL
    • rhNGF 4 µg/mL
    • Wien, Austria
      Department of Clinical Pharmacology
    Dec 14, 2022

    Overactive Bladder Trial in Seoul (Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium)

    Completed
    • Overactive Bladder
    • Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 28, 2019

    Micronerves in Dupuytren and Impact of Its Dissection on

    Not yet recruiting
    • Dupuytren's Disease
    • Microfasciectomy
    • Leuven, Vlaams-Brabant, Belgium
      Universitaire Ziekenhuizen KU Leuven
    Nov 15, 2023

    Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor Trial in Seoul (Holmium Laser Enucleation of the

    Completed
    • Benign Prostatic Hypertrophy With Outflow Obstruction
    • Overactive Detrusor
    • Holmium Laser Enucleation of the Prostate (HoLEP)
    • Holmium laser enucleation system and morcellator
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 28, 2019

    Symptoms of Overactive Bladder and Pelvic Organ Prolapse

    Recruiting
    • Overactive Bladder
    • Urinary Nerve Growth Factor
    • Thessaloníki, Central Macedonia, Greece
      Aristotle University of Thessaloniki
    Dec 1, 2021

    Healthy Volunteers Trial in Chengdu (EP-9001A, )

    Recruiting
    • Healthy Volunteers
    • Chengdu, Sichuan, China
      West China Hospital,Sichuan University
    Mar 30, 2022

    Injury of Optic Nerve Trial in Beijing (Recombinant human nerve growth factor injection,experimental, Recombinant human nerve

    Recruiting
    • Injury of Optic Nerve
    • Recombinant human nerve growth factor injection,experimental
    • +2 more
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    Aug 10, 2021

    Validation of a Novel Cortical Biomarker Signature for Pain

    Recruiting
    • TMD
    • Injection of Nerve Growth Factor
    • Baltimore, Maryland
    • +1 more
    Jul 11, 2022

    Temporomandibular Joint Disorders Trial in Alexandria (Nd-YAG Fotona, Epidermal Growth Factor)

    Enrolling by invitation
    • Temporomandibular Joint Disorders
    • Nd-YAG Fotona
    • Epidermal Growth Factor
    • Alexandria, الإسكندرية, Egypt
      Alexandria University
    Sep 13, 2023

    Nerve Growth Factor for the Treatment of Cornea Disease

    Completed
    • Neurotrophic Keratitis
    • Stanford, California
      Stanford University
    Dec 10, 2021

    Organ Protection Trial (Lidocaine, Normal saline (NS))

    Not yet recruiting
    • Organ Protection
    • (no location specified)
    Aug 13, 2022

    HIV, Peripheral Nervous System Disease Trial in United States (Nerve Growth Factor, Recombinant Human)

    Completed
    • HIV Infections
    • Peripheral Nervous System Disease
    • Nerve Growth Factor, Recombinant Human
    • Los Angeles, California
    • +13 more
    Oct 27, 2021

    Type II Diabetes With Neurological Manifestations Trial (Phsical Activity, Medication)

    Not yet recruiting
    • Type II Diabetes Mellitus With Neurological Manifestations
    • (no location specified)
    Oct 20, 2023

    Alcohol-induced Brain Injury Trial in Guangzhou (Nerve Growth Factor, Edaravone, Combination of vitamin B1, B6, C, E and

    Unknown status
    • Alcohol-induced Brain Injury
    • Nerve Growth Factor
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Oct 24, 2020

    Peripheral Neuropathy Due to Chemo Trial in Cairo (Losartan)

    Recruiting
    • Peripheral Neuropathy Due to Chemotherapy
    • Cairo, Egypt
      Breast Cancer Comprehensive Center of the National Cancer Instit
    Nov 26, 2023